Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients

International Journal of COPD

Volumn 10, Issue , 2015, Pages 745-757

  Nagai, Katsura ^a   Makita, Hironi ^a   Suzuki, Masaru ^a   Shimizu, Kaoruko ^a   Konno, Satoshi ^a   Ito, Yoichi M ^b   Nishimura, Masaharu ^a   On behalf of the Hokkaido COPD Cohort Study Investigators, ^p   Kawakami, Yoshikazu ^c   Nishiura, Youichi ^c   Saito, Hiroshi ^c   Kojima, Tetsuya ^c   Igarashi, Takeshi ^d   Kimura, Kiyonobu ^d   Nakano, Ikuo ^d   Katabami, Moto ^d   Itabashi, Kouichi ^d   Morikawa, Kiyoshi ^d   Tagami, Seiichi ^d   Otsuka, Yoshihiro ^d   Sato, Rika ^d   Kojima, Junichiro ^d   Nigawara, Shinji ^d   Morioka, Takashi ^d   Sakai, Ichiro ^d   Yamamoto, Hiroshi ^e   Ogura, Shigeaki ^e   Akie, Kenji ^e   Honmura, Fumihiro ^e   Kusudou, Shinichi ^e   Izumi, Hiroshi ^e   Baba, Kensuke ^e   Goya, Hiroki ^e   Nakano, Tsuyoshi ^f   Takeyabu, Kimihiro ^g   Akiyama, Yasushi ^h   Kishi, Fujiya ⁱ   Ito, Akihide ^h   Fujino, Michihiro ^h   Ohe, Masashi ^h   Harada, Toshiyuki ^h   Kamimura, Akira ⁱ   Hakuma, Nobuyuki ⁱ   Sukou, Noriaki ⁱ   Takaoka, Kazuo ^j   Doi, Isamu ^j   Ishimine, Atsushi ^k   Nakano, Ryouji ^k   Hasegawa, Yasushi ^l   Nasuhara, Yasuyuki ^a   Betsuyaku, Tomoko ^a   Hamada, Kunio ^a   Ito, Yoko ^a   Kobayashi, Motoko ^a   Hosokawa, Takeshi ^a   Fuke, Satoshi ^a   Hasegawa, Masaru ^a   Odajima, Nao ^a   Moriyama, Chinatsu ^a   Yoshida, Takayuki ^a   Inomata, Takashi ^a   Maki, Kanako ^a   Shibuya, Eiji ^a   Sasaki, Tsukasa ^m   Nitta, Katsuaki ^m   Yamamoto, Masafumi ^m   Mizuno, Shigetaka ^m   Miyamoto, Kenji ⁿ   Hizawa, Nobuyuki ^o   more..

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KKR Sapporo Medical Center   (Japan)

^d Japan Labor Health and Welfare Organization   (Japan)

^e SAPPORO CITY GENERAL HOSPITAL   (Japan)

^f Otaru City Hospital   (Japan)

^g Department of Gastroenterology   (Japan)

^h Hokkaido Social Insurance Hospital   (Japan)

ⁱ Iwamizawa City General Hospital   (Japan)

^j Department of Hematology   (Japan)

^k Kin ikyo Chuo Hospital   (Japan)

^l Tenshi Hospital   (Japan)

^m HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

ⁿ HOKKAIDO UNIVERSITY   (Japan)

^o UNIVERSITY OF TSUKUBA   (Japan)

^p NONE

more..

Author keywords

Annual change; Exacerbation; Forced expiratory volume in 1 second; SGRQ; Smoking

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT;

AGING; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DRUG USE; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PHYSICAL ACTIVITY; PREDICTION; QUALITY OF LIFE; RISK ASSESSMENT; SCORING SYSTEM; SMOKING; ST. GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOM; TREATMENT RESPONSE; ADVERSE EFFECTS; AGE; DRUG EFFECTS; JAPAN; LONGITUDINAL STUDY; LUNG; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRE; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ADRENERGIC BETA-AGONISTS; AGE FACTORS; BODY MASS INDEX; BRONCHODILATOR AGENTS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; JAPAN; LONGITUDINAL STUDIES; LUNG; MALE; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS; SMOKING; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84929396306     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S77586     Document Type: Article

References (29)

1. Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011;20(3):257–268.
2. Jones PW. Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001;56(11):880–887.
3. Jones PW, Quirk FH, Baveystock CM. The St George’s Respiratory Questionnaire. Respir Med. 1991;85(Suppl B):25–31; discussion 33–37.
4. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6):1321–1327.
5. Vestbo J, Edwards LD, Scanlon PD, et al; ECLIPSE Investigators. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365(13):1184–1192.
6. Nishimura M, Makita H, Nagai K, et al; Hokkaido COPD Cohort Study Investigators. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(1):44–52.
7. Casanova C, de Torres JP, Aguirre-Jaíme A, et al. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am J Respir Crit Care Med. 2011;184(9):1015–1021.
8. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med. 2007;101(1):146–153.
9. Kesten S, Celli B, Decramer M, Liu D, Tashkin D. Adverse health consequences in COPD patients with rapid decline in FEV1 – evidence from the UPLIFT trial. Respir Res. 2011;12:129.
10. Fabbri L, Pauwels RA, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary updated 2003. COPD. 2004;1(1):105–141; discussion 103–104.
11. Donaldson GC, Wedzicha JA. COPD exacerbations. 1: Epidemiology. Thorax. 2006;61(2):164–168.
12. Suzuki M, Makita H, Ito YM, Nagai K, Konno S, Nishimura M; Hokkaido COPD Cohort Study Investigators. Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study. Eur Respir J. 2014;43(5):1289–1297.
13. Little RJ, D’Agostino R, Cohen ML, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012;367(14):1355–1360.
14. Yorgancioglu A, Havlucu Y, Celik P, Dinc G, Saka A. Relation between quality of life and morbidity and mortality in COPD patients: Two-year follow-up study. COPD. 2010;7(4):248–253.
15. Oga T, Tsukino M, Hajiro T, Ikeda A, Nishimura K. Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study. Respir Res. 2012;13:85.
16. Foglio K, Bianchi L, Bruletti G, et al. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs. Respir Med. 2007;101(9):1961–1970.
17. Tashkin DP, Celli B, Kesten S, Lystig T, Mehra S, Decramer M. Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial. Eur Respir J. 2010;35(2):287–294.
18. Ferrari R, Tanni SE, Caram LM, Naves CR, Godoy I. Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2011;9:112.
19. Troosters T, Celli B, Lystig T, et al; Uplift Investigators. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Eur Respir J. 2010;36(1):65–73.
20. Jones PW, Anderson JA, Calverley PM, et al; TORCH investigators. Health status in the TORCH study of COPD: treatment efficacy and other determinants of change. Respir Res. 2011;12:71.
21. Spencer S, Calverley PM, Sherwood Burge P, Jones PW; ISOLDE Study Group. Inhaled Steroids in Obstructive Lung Disease. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163(1):122–128.
22. Wilke S, Spruit MA, Wouters EF, Schols JM, Franssen FM, Janssen DJ. Determinants of 1-year changes in disease-specific health status in patients with advanced chronic obstructive pulmonary disease: a 1-year observational study. Int J Nurs Pract. Epub 2014 Mar 26.
23. Westwood M, Bourbeau J, Jones PW, Cerulli A, Capkun-Niggli G, Worthy G. Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res. 2011;12:40.
24. Donohue JF, Fogarty C, Lötvall J, et al; INHANCE Study Investigators. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med. 2010;182(2):155–162.
25. Monteagudo M, Rodríguez-Blanco T, Llagostera M, et al. Factors associated with changes in quality of life of COPD patients: a prospective study in primary care. Respir Med. 2013;107(10):1589–1597.
26. Jones PW. St George’s Respiratory Questionnaire: MCID. COPD. 2005;2(1):75–79.
27. Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med. 2014;189(3):250–255.
28. Jones PW, Mahler DA, Gale R, Owen R, Kramer B. Profiling the effects of indacaterol on dyspnoea and health status in patients with COPD. Respir Med. 2011;105(6):892–899.
29. Lareau SC, Breslin EH, Meek PM. Functional status instruments: outcome measure in the evaluation of patients with chronic obstructive pulmonary disease. Heart Lung. 1996;25(3):212–224.